Hyperammonemic encephalopathy induced by a combination of valproate and pivmecillinam

Acta Neurologica Scandinavica

Volumn 109, Issue 4, 2004, Pages 297-301

  Lokrantz, C M ^a   Eriksson, B ^a   Rosen I ^a   Asztely, F ^a,b  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Epilepsy; Hyperammonemic encephalopathy; Pivmecillinam; Triphasic waves; Valproate

Indexed keywords

CARNITINE; CEFUROXIME; PIVMECILLINAM; VALPROIC ACID;

AGED; AMMONIA BLOOD LEVEL; ARTICLE; BRAIN DISEASE; CASE REPORT; CLINICAL FEATURE; CONVALESCENCE; DELTA RHYTHM; DETERIORATION; DRUG WITHDRAWAL; ELECTROENCEPHALOGRAM; FEMALE; FOCAL EPILEPSY; HUMAN; HYPERAMMONEMIA; HYPERAMMONEMIC ENCEPHALOPATHY; MONOTHERAPY; NEUROPHYSIOLOGY; RARE DISEASE; RISK ASSESSMENT; STUPOR; THETA RHYTHM; URINARY TRACT INFECTION;

AGED; AMDINOCILLIN PIVOXIL; ANTI-BACTERIAL AGENTS; ANTICONVULSANTS; BRAIN DISEASES; FEMALE; HUMANS; HYPERAMMONEMIA; VALPROIC ACID;

EID: 1642524978     PISSN: 00016314     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1600-0404.2003.00227.x     Document Type: Article

References (17)

1. SACKELLARES JC, LEE SI, DREIFUSS FE. Stupor following administration of valproic acid to patients recieving other antiepileptic drugs. Epilepsia 1979;20:697-703.
2. COULTER DL, ALLEN RJ. Secondary hyperammonaemia: a possible mechanism for valproate encephalopathy. Lancet 1980;1:1310-1.
3. ZARET BS, BECKNER RR, MARINI AM, WAGLE W, PASSARELLI C. Sodium valproate-induced hyperammonemia without clinical hepatic dysfunction. Neurology 1982;32:206-8.
4. DUARTE J, MACIAS S, CORIA F, FERNANDEZ E, CLAVERIA LE. Valproate-induced coma: case report and literature review. Ann Pharmacother 1993;27:582-3.
5. HAMER HM, KNAKE S, SCHOMBURG MA, ROSENOW F. Valproate-induced hyperammonemic encephalopathy in the presence of topiramate. Neurology 2000;54:230-2.
6. KIFUNE A, KUBOTA F, SHIBATA N, AKATA T, KIKUCHI S. Valproic acid-induced hyperammonemic encephalopathy with triphasic waves. Epilepsia 2000;41:909-12.
7. OECHSNER M, STEEN C, STÜRENBURG HJ, KOHLSCHÜTTER A. Hyperammonaemic encephalopathy after initiation of valproate therapy in unrecognised ornithine transcarbamylase deficiency. J Neurol Neurosurg Psychiatry 1988;64:680-2.
8. FARKAS V, BOCK I, CSEKO J, SANDOR A. Inhibition of carnitine biosynthesis by valproic acid in rats - the biochemical mechanisms of inhibition. Biochem Pharmacol 1996;52:1429-33.
9. VERROTTI A, GRECO R, MORGESE G, CHIARELLI F. Carnitine deficiency and hyperammonemia in children receiving valproic acid with and without other anticonvulsant drugs. Int J Clin Lab Res 1999;21:36-40.
10. WARTER JM, BRANDT C, MARESCAUX C et al. The renal origin of sodium valproate-induced hyperammonemia in fasting humans. Neurology 1983;33:1136-40.
11. HOLME E, JACOBSSON CE, NORDIN I et al. Carnitine deficiency induced by pivampicillin and pivmecillinam therapy. Lancet 1989;26:469-72.
12. ABRAHAMSSON K, HOLME E, JODAL U, LINDSTEDT S, NORDIN I. Effect of short-term treatment with pivalic acid containing antibiotics on serum carnitine concentrations - a risk irrespective of age. Biochem Mol Med 1995;55:77-9.
13. MELEGH B, KORNER J, JASZAI V, BIEBER L. Differential excretion of xenobiotic acyl-esters of carnithine due to administration of pivampicillin and valproate. Biochem Med Metabol Biol 1990;43:30-8.
14. Information from the Swedish Medical Product Agency. 1991;3:145-6.
15. SAMTOY B, DEBEUKELAER M. Ammonia encephalopathy secondary to urinary tract infection with Proteus Mirabillis. Pediatrics 1980;65:294-7.
16. KUNTZE J, WEINBERG A, AHLERING T. Hyperammonemic coma due to Proteus infection. J Urol 1985;134:972-3.
17. KAVEGGIA F, THOMPSON J, SCHAFER E, FISCHER J, TAYLOR R. Hyperammonemic encephalopathy in urinary diversion with urea-splitting urinary tract infection. Arch Intern Med 1990;150:2389-92.